The Multiple Myeloma Research Foundation has teamed up with the Cancer Research Institute and our partner, Ludwig Cancer Research, to co-fund an early-phase clinical trial that is testing immunotherapy in combination with autologous stem cell transplant and chemotherapy in the treatment of patients with multiple myeloma who are at high risk for recurrence.

*Immunotherapy results may vary from patient to patient.